Ongoing
CTN 327: Impact of COVID-19 on persons with HIV in Canada
The impact of COVID-19 on persons with HIV in Canada: Data from the HIV/HCV co-infection/CCC (CTN 222) and HIV aging cohorts (CTN 314)
Learn MoreOngoing
The impact of COVID-19 on persons with HIV in Canada: Data from the HIV/HCV co-infection/CCC (CTN 222) and HIV aging cohorts (CTN 314)
Learn MoreEnrolling
Completed
BonE health in ageING Women: improvement or prevention of changes in bone mineral density by switching antiretroviral agents
Learn MoreCompleted
Valacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial
Learn MoreCompleted
Can valacylovir attenuate inflammation in ART-treated HIV-infected individuals with herpes simplex virus type 2? Trial results
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.